U.S. Physical Therapy, Inc. (USPH)
NYSE: USPH · Real-Time Price · USD
74.99
-0.61 (-0.81%)
May 30, 2025, 4:00 PM - Market closed
U.S. Physical Therapy Market Cap
U.S. Physical Therapy has a market cap or net worth of $1.14 billion as of May 30, 2025. Its market cap has decreased by -27.97% in one year.
Market Cap
1.14B
Enterprise Value
1.41B
1-Year Change
-27.97%
Ranking
Category
Stock Price
$74.99
Market Cap Chart
Since December 1, 1998, U.S. Physical Therapy's market cap has increased from $33.40M to $1.14B, an increase of 3,310.85%. That is a compound annual growth rate of 14.24%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 29, 2025 | 1.15B | -14.23% |
Dec 31, 2024 | 1.34B | -4.07% |
Dec 29, 2023 | 1.40B | 32.50% |
Dec 30, 2022 | 1.05B | -14.61% |
Dec 31, 2021 | 1.23B | -20.16% |
Dec 31, 2020 | 1.55B | 5.79% |
Dec 31, 2019 | 1.46B | 12.51% |
Dec 31, 2018 | 1.30B | 42.92% |
Dec 29, 2017 | 908.40M | 3.34% |
Dec 30, 2016 | 879.00M | 31.82% |
Dec 31, 2015 | 666.80M | 29.53% |
Dec 31, 2014 | 514.80M | 20.59% |
Dec 31, 2013 | 426.90M | 30.63% |
Dec 31, 2012 | 326.80M | 40.26% |
Dec 30, 2011 | 233.00M | 1.00% |
Dec 31, 2010 | 230.70M | 17.34% |
Dec 31, 2009 | 196.60M | 23.34% |
Dec 31, 2008 | 159.40M | -6.24% |
Dec 31, 2007 | 170.00M | 20.14% |
Dec 29, 2006 | 141.50M | -35.94% |
Dec 30, 2005 | 220.90M | 15.17% |
Dec 31, 2004 | 191.80M | 8.67% |
Dec 31, 2003 | 176.50M | 34.94% |
Dec 31, 2002 | 130.80M | -22.97% |
Dec 31, 2001 | 169.80M | 118.25% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 648.84B |
Johnson & Johnson | 367.79B |
AbbVie | 327.19B |
Novo Nordisk | 305.07B |
UnitedHealth Group | 268.74B |
Abbott Laboratories | 230.35B |
Novartis AG | 219.70B |
AstraZeneca | 216.88B |